| MolName | [[(2S,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate |
| MolecularFormula | C9H15N2O15P3 |
| Smiles | O[C@@H]([C@H](COP(O)(OP(O)(OP(O)(O)=O)=O)=O)O[C@H]1N(C=CC(N2)=O)C2=O)[C@H]1O |
| InChI | InChI=1S/C9H15N2O15P3/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m0/s1 |
| InChIK | PGAVKCOVUIYSFO-PSQAKQOGSA-N |
| TotalMolweight | 484.139 |
| Molweight | 484.139 |
| MonoisotopicMass | 483.968534 |
| CLogP | -10.702 |
| CLogS | 3.141 |
| H Acceptors | 17 |
| H Donors | 7 |
| TotalSurfaceArea | 283.43 |
| Relative PSA | 0.74357 |
| PolarSurfaceArea | 288.35 |
| Druglikeness | -34.18 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.55172 |
| Fragments | 1 |
| Non HAtoms | 29 |
| NonCHAtoms | 20 |
| Electronegative Atoms | 20 |
| StereoCenters | 6 |
| Rotatable Bond | 8 |
| Rings Closures | 2 |
| Small Rings | 2 |
| Sp3Atoms | 18 |
| Symmetricatoms | 1 |
| Amides | 2 |
| AcidicOxygens | 4 |
| StereoCon | unknown chirality |
Click to Load Molecule:
1 - [[(2S,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | 2 - [[(2S,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate